Physician profile
John Robert Hunter
NPI 1184963662
$1,609.90
in general payments reported to CMS, 2019-2025
11 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $104 · 2023: $1,229 · 2024: $162 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853 · Travel and Lodging: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.07 |
| Travel and Lodging | $652.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Consultants | $751.21 | 2023-2024 | |
| Arthrex, INC. | $433.75 | 2023 | |
| Organogenesis INC. | $128.10 | 2023-2025 | Puraply, Affinity, Puraply Wound Matrix |
| Novus Surgical Solutions LLC | $87.91 | 2022 | |
| Tactile Systems Technology INC | $54.32 | 2025 | Flexitouch Plus, Nimbl |
| Paratek Pharmaceuticals, INC. | $41.80 | 2023-2024 | Nuzyra |
| Lifenet Health | $36.31 | 2023-2024 | Theragenesis Wound Matrix |
| Intuitive Surgical, INC. | $24.18 | 2025 | |
| Bioventus LLC | $23.00 | 2023 | |
| Kci USA, INC. | $16.48 | 2022 | |
| Nevro Corp. | $12.84 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.